Inlyta is a prescription medication used to treat advanced renal cell cancer. Inlyta is an oral medication prescribed after other treatments have not shown to be effective in slowing the growth of cancer cells, or if the previous medication has stopped working. Inlyta is part of a class of drugs referred to as tyrosine kinase inhibitors, that work by obstructing the activity of abnormal proteins that alerts cancer cells to flourish. This aids in slowing or stopping the multiplication of cancer cells.
Drug Name: Inlyta
Generic name: Axitinib